TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition.

about

The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.

P2860

Q27928010-2F2EF64C-DA34-4A9C-8993-0457DCEB5FD5 Q50113702-864F2337-5EF6-4312-95C7-543F86912E0D

P2860

TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition.

Item

http://www.wikidata.org/entity/Q53814929

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition.

@en

TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition.

@nl

type

Item

label

TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition.

@en

TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition.

@nl

prefLabel

TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition.

@en

TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition.

@nl

P1476

TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition.

@en

P2093

D J Pinato

http://www.w3.org/2001/XMLSchema#string

J Stebbing

http://www.w3.org/2001/XMLSchema#string

S Chowdhury

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2013

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer.

AXL mediates resistance to cetuximab therapy

Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET.

Heterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics

Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells.

Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?

Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.

P2888

onc.2015.374

P304

2684-2686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2015.374

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26434595

http://www.w3.org/2001/XMLSchema#string

TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition.

about

P2860

P2860

TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698